CUREVAC N.V. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.535 USD | +8.80% |
|
0.00% | -39.90% |
| Apr. 26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
| Apr. 25 | Leerink Partners Downgrades CureVac to Market Perform From Outperform, Sets Price Target at $4 | MT |
Chart calendar CureVac N.V.
7fbf3e66bb2d3d8fb4a2f7de220ae8.feL9KfzI4L_UJVysEc_4q-v19iS3_8Y3E8oaMBPFaBw.G4SUYpiL0vOlFDrfSIWVxJqdkWyExqhNfJlsYlK_CkwP068emrm455N6FQ~50c424ecaa8ccc99ce4898f602e1d1ba
Upcoming events on CureVac N.V.
Past events on CureVac N.V.
| 2024-04-24 09:00 am | Q4 2023 Earnings Call |
| 2024-04-24 07:06 am | Q4 2023 Earnings Release |
| 2024-04-15 | Van Lanschot Kempen Life Sciences Conference |
| 2024-02-07 11:30 am | Guggenheim Healthcare Talks Biotechnology Conference |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2023-11-29 02:57 pm | Piper Sandler Healthcare Conference |
| 2023-11-28 09:10 am | Evercore ISI HealthCONx Conference |
| 2023-11-15 10:00 am | Jefferies London Healthcare Conference |
| 2023-11-14 09:00 am | Q3 2023 Earnings Call |
| 2023-11-14 07:00 am | Q3 2023 Earnings Release |
| 2023-10-30 | International mRNA Health Conference |
| 2023-09-11 | Morgan Stanley Global Healthcare Conference |
| 2023-08-17 07:00 am | Q2 2023 Earnings Release |
| 2023-06-19 08:00 am | Annual General Meeting |
| 2023-06-07 12:00 am | Jefferies Global Healthcare Conference |
| 2023-05-30 07:00 am | Q1 2023 Earnings Release |
| 2023-05-15 12:00 am | JMP Securities Life Sciences Conference |
| 2023-05-08 | Bank of America Healthcare Conference |
| 2023-04-25 | Kempen Lifesciences Conference |
| 2023-04-25 09:00 am | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 17,4 | 48,9 53,3 -8.17% | 103 74,7 37.9% | 67,4 73,4 -8.19% | 53,8 66,3 -18.8% | 71,1 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 | -99,1 -151 34.51% | -762 -521 -46.45% | -226 -190 -19.04% | -251 -185 -35.3% | -197 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | -110 -162 32.22% | -778 -529 -47.19% | -249 -196 -27.26% | -274 -210 -30.42% | -220 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | -130 -122 -6.83% | -412 -525 21.5% | -249 -205 -21.25% | -260 -186 -39.71% | -192 |
|
Net income Million EUR | Released Forecast Spread | 0,00 | -129 -168 22.93% | -412 -531 22.42% | -249 -199 -24.98% | -260 -199 -30.71% | -174 |
|
EPS EUR | Released Forecast Spread | -137 | -0,98 -1,81 45.96% | -2,21 -3,29 32.9% | -1,32 -1,04 -26.45% | -1,18 -0,95 -24.78% | -0,83 |
| Announcement Date | 29/04/20 | 15/04/21 | 28/04/22 | 25/04/23 | 24/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 41,2 4,15 893.37% | 24,4 23,0 6.09% | 20,1 16,5 21.82% | 11,2 20,2 -44.46% | 11,7 15,9 -26.63% | 7,13 12,4 -42.5% | 7,58 13,7 -44.88% | 16,5 16,0 3.27% | 22,6 29,1 -22.29% | 17,8 | 17,8 | 17,8 | 17,8 | 3,55 |
|
EBIT Million EUR | Released Forecast Spread | -371 -119 -210.98% | -15,3 -98,0 84.42% | -60,3 -60,6 0.54% | -52,4 -46,6 -12.39% | -122 -45,3 -168.17% | -60,4 -70,0 13.72% | -71,8 -55,6 -29.12% | -54,0 -52,2 -3.5% | -88,0 -36,0 -144.59% | -60,0 | -56,4 | -54,5 | -53,7 | -64,8 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -4,56 -78,4 94.18% | -15,2 -98,0 84.49% | -57,6 -40,0 -44% | -129 -60,0 -114.58% | -57,4 -52,0 -10.42% | -67,4 -47,0 -43.38% | -48,7 -52,0 6.35% | -86,5 -28,0 -208.93% | -55,0 | -52,0 | -51,0 | -52,0 | ||
|
Net income Million EUR | Released Forecast Spread | -1,94 -78,4 97.53% | -15,1 -98,0 84.6% | -57,6 -40,0 -43.96% | -129 -60,0 -114.64% | -57,4 -52,0 -10.42% | -67,4 -43,4 -55.33% | -48,7 -37,3 -30.51% | -86,7 -25,3 -242.5% | -41,7 | -40,2 | -39,7 | -40,2 | ||
|
EPS EUR | Released Forecast Spread | 0,00 -0,42 - | -0,08 -0,52 84.62% | -0,31 -0,17 -82.35% | -0,25 -0,31 19.35% | -0,68 -0,34 -99.94% | -0,27 -0,38 29.17% | -0,30 -0,22 -34.51% | -0,22 -0,24 7.9% | -0,39 -0,18 -112.38% | -0,23 | -0,22 | -0,21 | -0,21 | -0,27 |
| Announcement Date | 28/04/22 | 25/05/22 | 18/08/22 | 16/11/22 | 25/04/23 | 30/05/23 | 17/08/23 | 14/11/23 | 24/04/24 | - | - | - | - | - |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for CureVac N.V.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CVAC Stock
- Calendar CureVac N.V.
